Health Insurance (Section 3C Co-Dependent Pathology Services) Amendment Determination (No. 3) 2018

I, CELIA STREET, delegate of the Minister for Health, make the following determination.

Dated        12 December 2018

 

 

 

Celia Street

Assistant Secretary

Diagnostic Imaging and Pathology Branch

Medical Benefits Division

Health Financing Group

Department of Health

 

 

 


 

1. Name

2. Commencement

3. Authority

4. Schedules

Schedule  1 – Amendment

 

 

 

 

 

 

 

 


1.                       Name

This instrument is the Health Insurance (Section 3C Co-Dependent Pathology Services) Amendment Determination (No. 3) 2018.

 

2.                       Commencement

This instrument commences on 1 January 2019.

3.                       Authority

This instrument is made under subsection 3C(1) of the Health Insurance Act 1973.

 

4.                       Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.


Schedule  1 – Amendment

 

Health Insurance (Section 3C Co-Dependent Pathology Services) Determination 2018

1  Schedule 1 (at the end of the table of Group P7)

Add:
 

73344

Fluorescence in situ hybridization (FISH) test of tumour tissue from a patient with locally advanced or metastatic non-small-cell lung cancer (NSCLC), which is of non-squamous histology or histology not otherwise specified, with documented evidence of ROS proto-oncogene 1 (ROS1)  immunoreactivity by immunohistochemical (IHC) examination giving a staining intensity score of 2+ or 3+; and with documented absence of both activating mutations of the epidermal growth factor receptor (EGFR) gene and anaplastic lymphoma kinase (ALK) immunoreactivity by IHC, requested by a specialist or consultant physician to determine if requirements relating to ROS1 gene rearrangement status for access to crizotinib under the Pharmaceutical Benefits Scheme are fulfilled.

 

400.00